Cancer Workforce Crisis Forecasted
Experts warn that the world is about to face a significant crisis in cancer care workforce, predicting a shortfall of 100 million personnel by 2050. This comes as approximately 100,000 new cancer diagnoses are made each day.
The anticipated rise in the global cancer burden may lead to much longer waiting times for patients seeking diagnosis and treatment. This information was highlighted in a report presented at a major oncology conference.
According to the research shared during the American Society of Clinical Oncology’s annual meeting in Chicago, there could be a staggering shortage of 100 million cancer care workers globally by 2050. The most affected areas are likely to be nursing, with roughly 65 million needed, and diagnostic staff, which may lack around 16 million workers.
Further complicating matters, the report predicts a 21% increase in cancer incidence over the coming years. Specifically, the rate is expected to jump from 165 cases per 100,000 people in 2025 to about 200 by 2050.
Currently, about 20 million people receive a cancer diagnosis each year. By 2050, that number might soar to over 35.3 million, indicating nearly 100,000 new cases daily.
During the launch of the report in Chicago, Mark Lawler, a co-author and professor at Queen’s University Belfast, described the findings as concerning. “We’re looking at conflicting numbers here—a projected 35 million cancer diagnoses each year against a 100 million decline in staffing for care. It’s crucial that we recognize this as a serious wake-up call globally,” he noted.
Lawler further emphasized the urgency, stating that diagnosing everyone with cancer, a challenge already, is becoming more critical as an estimated 18.5 million cancer-related deaths could be seen annually by 2050.
The report mentions that currently, one in three cancer cases goes undiagnosed worldwide, with some regions in Africa experiencing up to 60% of cancer patients remaining undiagnosed.
In contrast, high-income nations have seen significant improvements in cancer survival rates due in large part to advancements in treatment and early detection methods.
While survival rates in these wealthy countries might exceed 60% by 2050, the report cautions that the workforce crisis will still negatively impact their ability to enhance outcomes.
Dr. Hedvig Hricak, another co-lead of the report from Memorial Sloan Kettering Cancer Center, pointed out the urgent need for action. “Our global initiative issues a clear warning: without immediate steps to tackle workforce shortages, we risk facing a cancer crisis of unprecedented scale,” she said.
She urged for targeted strategies in each country, advocating for intelligent resource utilization, the integration of AI and digital health, as well as strong funding through public-private partnerships to meet these challenges.
The report recommends several approaches to mitigate the predicted workforce shortage. These include developing national cancer control plans with workforce development integrated, investing in technology and education, and enhancing both regional and international collaborations for sustainable funding.
Investing in the cancer workforce could prevent 170 million cancer deaths between 2030 and 2050, potentially yielding an estimated $120 trillion in net economic benefits.
Dr. Peter Kingham, also a co-author and director of a global cancer research program, emphasized the importance of preventive measures, like promoting healthier lifestyles. However, he stressed that urgent steps to address the workforce crisis are essential given the increasing global population that will inevitably face a higher cancer risk.
“Cancer is primarily a disease of aging,” he noted. “As life expectancy increases and chronic conditions become manageable, more individuals are living long enough to confront cancer risks. This demographic shift is a sign of progress but calls for an equally ambitious response in cancer care.”
